Clinical study of an anthroposophic treatment strategy for early rheumatoid arthritis, compared to conventional long-term therapy

Phase 4

• Conditions: M06.9; Rheumatoid arthritis, unspecified

• Registration Number: DRKS00011083
• Lead Sponsor: FilderklinikGemeinnütziges Gemeinschaftskrankenhaus

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2003-12-19
• Study Start: 2016-09-23
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 251

Inclusion Criteria

Rheumatoid arthritis according to the 1987 American College of Rheumatology criteria. Independent confirmation of diagnosis by experienced rheumatologist.

Exclusion Criteria

[1] Disease duration > 3 years since onset of initial symptoms (painful swelling of RA-typical joints or tenosynovitis of the hands;
[2] other rheumatic disorders;
[3] previous treatment with disease modifying anti rheumatic drugs (DMARDs);
[4] high-dose iv. corticosteroids or intraarticular corticosteroid injections in the past six weeks
[5] radiological or medical synovectomy in the past six weeks;
[6] previous surgical synovectomy;
[7] severe concomitant disorders (e.g. malignant disease, severe hepatic disease, renal insufficiency);
[8] substance abuse (alcohol, drugs or chemicals), mental disorders;
[9] conditions that could mimic RA (e.g. acute infections, osteomalacia, neurological diseases);
[10] personality disorders or life circumstances with increased risk of lack of cooperation during the study;
[11] current pregnancy or puerperium;
[12] participation in another clinical study of rheumatoid arthritis during follow-up

Study & Design

• Study Type: interventional
• Study Design: Not specified